Second Annual
JANICE
ANTOINE LUMPKIN
MEMORIAL LECTURE
"U.S. BIOTECHNOLOGY STATUS"
Speaker: Dr. Daniel I.C. Wang
Institute Professor of Chemical Engineering
Department of Chemical Engineering Massachusetts
Institute of Technology
Location: Lecture Hall V
Engineering/Computer
Science (ECS) Building, UMBC
Free and open to the public
Directions
to Campus
Visitor
Parking (metered parking in lot 10)
The US has played a major role to lead the research and industrial development in biotechnology. This leadership was the direct result on the far-sightedness of our Federal Government's basic research policies in supporting the basic research that has led to the development of the biotechnology industry in the US. Today, there are over 1,400 biotechnology companies in the US. The major companies in this industry are highly valued as a result of the biotherapeutics which they have placed on the market in the treatment of human diseases. These companies are also highly valued by the investment community where the major financial resources have been raised to support their activities.
On the other hand, the present biotechnology industry,
on the whole, has not been profitable since its inception. This has led
to some major changes in the past five years as to how this industry will
develop in the years to come. It is the intent of this lecture to highlight
some of the past achievements in this industry as well as to present what
will be happening in its future.
![]() |
Daniel
I.C. Wang
Professor Daniel I.C. Wang obtained his B.S. and M.S. degrees at the Massachusetts Institute of Technology, and his Ph.D. degree at the University of Pennsylvania. He is currently the Institute Professor of Chemical Engineering at the Massachusetts Institute of Technology. Professor Wang's research and teaching interests are principally in the area of biochemical engineering. He has published 5 books and over 200 technical articles in journals, and is widely regarded as one of the leaders in his field. His most recent research interests include studies of the use of reaction network modeling of animal cell metabolism to improve therapeutic protein production in bioreactors. He has also recently been interested in characterizing the heterogeneity of glycosylated proteins using mass spectroscopy and related bioanalytical methods, and in controlling the structure of the glycan moieties of glycosylated proteins during the production of proteinaceous drugs. Professor Wang is on the editorial boards of 12 journals in the biotechnology field, including Biotechnology and Bioengineering (where he is editor-in-chief), Advances in Biotechnology, Biotechnology and Bioprocess Journal, and Applied and Environmental Biotechnology. He is a member of the National Academy of Engineering and the American Academy of Arts of Sciences, and a Founding Fellow of the American Institute of Medical and Biological Engineering. He is also a recipient of the M. J. Johnson Award from the American Chemical Society, the Asia-Pacific Distinguished Biochemical Engineering Award, and the William H. Walker Award and the Food, Pharmaceutical and Bioengineering Award from the American Institute of Chemical Engineers. |
| Last updated April 1999
Comments: cbe-webmaster@umbc.edu |